CEQUR
CeQur SA is dedicated to developing and commercializing advanced insulin delivery systems that make it easier for people living with type 2 diabetes to comply with therapy and stay in control of their disease. CeQur is developing the CeQurâ„¢ Insulin Infuser, a simple and discrete insulin delivery tool for people who could benefit from intensive insulin therapy but want flexibility and freedom from multiple daily injections. CeQur was established in January 2008 as a spin out from Danfoss A/S, a large, global Danish industrial products group. The company is headquartered in Montreux, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.
CEQUR
Industry:
Biotechnology Delivery Diabetes Health Care Medical Medical Device
Founded:
2008-01-01
Address:
Horw, Luzern, Switzerland
Country:
Switzerland
Website Url:
http://www.cequrcorp.com
Total Employee:
101+
Status:
Active
Contact:
+41415004862
Email Addresses:
[email protected]
Total Funding:
271.6 M USD
Technology used in webpage:
Domain Not Resolving Amazon GoDaddy DNS AWS Global Accelerator
Similar Organizations
Armune BioScience
Armune BioScience develops and commercializes molecular diagnostic and prognostic tests for prostate, lung and breast cancers.
Biogroup-LCD
Biogroup-LCD is a player in local medical biology,supports more than 20,000 patients every day and offers more than 2000 routine.
Biom'Up
Biom'Up is a French company that specialises in the manufacture of re-absorbable medical devices based on collagen technology.
BIOS
A full-stack neural interface platform, that uses AI to decode and encode the signals from to the body, to treat chronic health conditions.
BrainQ
BrainQ develops a platform for precision neurology therapies to treat the impaired brain using a BCI-based approach.
CancerAid
CancerAid empowers people and organisations affected by cancer to thrive through expertise, empathy and technology
Kuur Therapeutics
Kuur Therapeutics is committed to transforming the lives of patients with cancer & is leading the development cell therapies.
Chronomics
Tech-bio company, providing access to a ‘bio-infrastructure’ to simplify and speed-up the use of biomarkers to improve everyday decisions.
CN Bio Innovations
CN Bio develops human organ-on-a-chip platforms for the testing and development of therapeutics for serious human diseases.
Companion Medical
Companion Medical develops a technology designed for those living with Type 1 or Type 2 insulin-dependent diabetes.
Creavo Medical Technologies
Creavo Medical Technologies is an innovative British company developing diagnostics technology for acute medical settings.
DAMAE Medical
DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection.
Impel NeuroPharma
Impel NeuroPharma is a medical device company that develops a novel drug delivery device that uses direct nose-to-brain delivery.
Injeq
Injeq is the smartest needle around – based on pioneering tissue identification technology.
Kerecis
Kerecis develops, manufactures, and markets implants and repair materials for the human body from omega3 rich fish skin.
Lattice Medical
Lattice Medical offers a 3D printed bioabsorbable medical device for breast reconstruction.
Mauna Kea Technologies
Mauna Kea Technologies specializes in designing, developing, and selling optical biopsy devices and tools.
Medicortex Finland Oy
Medicortex Finland is developing the first, non-invasive, point-of-care diagnostic test for Traumatic Brain Injury.
Talam Biotech
Talam Biotech uses nature's microbes to reduce toxins in crops while increasing crop yields and reducing pollutants in arable soil.
Mimetas
MIMETAS develops organ-on-a-chip tissue- and disease models for better, more reliable, and tailored medicines.
Mimetis Biomaterials
Mimetis Biomaterials designs, manufactures and commercializes biomimetic bone regenerative solutions in the dental and orthopaedic fields.
MIVI Neuroscience
MIVI Neuroscience focuses on developing and commercializing clinical solutions for neurointerventional procedures.
Nightbalance
Nightbalance has created a device called the Sleep Position Trainer
Sonosine
A deep-tech firm set to dramatically improve clinical decision making with an advanced world-class medical imaging device
Oxitec
Oxitec develops an environment-friendly technology for the control of significant insect pests to prevent diseases and agricultural damage.
Perfuze
Perfuze is developing innovative medical technology to treat acute ischemic stroke.
PredictImmune
Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
ProTip
ProTip develops innovative solutions for patients suffering from larynx malfunctions.
Rapid Medical
is to develop safe and effective neurovascular medical devices that are beneficial to patients and meet physicians' needs
RTsafe
RTsafe developed, patented and commercialized the worlds first Personalized Care service (FDA cleared) in Radiation Oncology.
Scandinavian Real Hearts
Scandinavian Real Hearts is a medical technology company that develops an artificial heart.
SiSaf
Delivering on the promise of RNA therapeutics
Tissue Regenix
Tissue Regenix commercializes innovative technologies in regenerative medicine.
Vascular Flow Technologies
Vascular Flow Tech focuses on research, development and commercialization of vascular devices based on new understanding of blood flow.
VLPbio
VLPbio focuses on research and development of chimeric virus like particles (VLPs) as vaccines in animal and human health.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-07-17 | Calibra Medical | Calibra Medical acquired by CeQur | N/A |
Investors List
GMS Capital Partners
GMS Capital Partners investment in Series C - CeQur
VI Partners
VI Partners investment in Series C - CeQur
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Series C - CeQur
Schroders
Schroders investment in Series C - CeQur
Tandem Diabetes Care
Tandem Diabetes Care investment in Series C - CeQur
Endeavour Vision
Endeavour Vision investment in Series C - CeQur
Kingdon Capital
Kingdon Capital investment in Series C - CeQur
Ypsomed
Ypsomed investment in Series C - CeQur
Credit Suisse Entrepreneur Capital
Credit Suisse Entrepreneur Capital investment in Series C - CeQur
VI Partners
VI Partners investment in Series C - CeQur
Official Site Inspections
http://www.cequrcorp.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "CeQur"
CeQur Corporation - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CeQur Corporation of Marlborough, MA. Get the latest business insights from Dun & Bradstreet.See details»
CeQur - Overview, News & Similar companies | ZoomInfo.com
Jun 18, 2024 Popular Searches CeQur Corp CeQur SA Cequr Security LLC Dashel Corp SIC Code 38,384 NAICS Code 33,334 Show more. CeQur Org Chart. Phone ... Phone Email. …See details»
CeQur | VentureRadar
Website: http://www.cequrcorp.com. CeQur is dedicated to developing and commercializing advanced insulin delivery devices that make it easier for people living with ...See details»
CeQur Simplicity Wearable Mealtime Insulin Patch
1. Bergenstal R, Peyrot M, Dreon D, Aroda V, Bailey T, Brazg R, Frias J, Johnson M, Klonoff D, Kruger D, Ramtoola S, Rosenstock J, Serusclat P, Weinstock R, Naik R, Shearer D, Zraick V, Levy B on behalf of the Calibra Study Group. …See details»
CeQur - LinkedIn
CeQur | 7,661 followers on LinkedIn. Our mission is to simplify the lives of people with diabetes | CeQur®, a medical device company dedicated to simplifying mealtime insulin delivery for ...See details»
Leadership - CeQur Simplicity
Timothy Bailey, MD Richard Bergenstal, MD Bruce Bode, MD George Grunberger, MD Davida Kruger, NP John Buse, MD Carol Wysham, MDSee details»
CeQur - Golden
CeQur is a company known for developing drug delivery devices for patients with type 2 diabetes. The company was founded in 2008, in Horw, Luzern, Switzerland.. The company primarily …See details»
About | Wearable Insulin Patch - CeQur Simplicity
CeQur ® is simplifying mealtime insulin delivery for people with type 1 and type 2 diabetes. Headquartered in Horw, Switzerland, with US Operational Headquarters in Greenville, South Carolina, CeQur is committed to making it easy for people …See details»
CeQur Appoints Rick Doubleday and Dr. Meret Gaugler …
Jun 25, 2021 Accomplished executives with decades of healthcare experience join board as CeQur Simplicityâ„¢ advances toward commercializationSee details»
CeQur Raises $115 Million Series C5 Financing to Support ...
Apr 13, 2021 LUCERNE, Switzerland & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Apr 13, 2021-- CeQur®, a medical device company committed to simplifying the lives of people with …See details»
CeQur Corporation Careers and Employment | Indeed.com
Mar 2, 2017 Find out what works well at CeQur Corporation from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for …See details»
CeQur Initiates Significant Facility Expansion in Marlborough - PR …
Apr 11, 2016 The Massachusetts Medical Device Industry Council, an organization of 330 manufacturers, suppliers, research institutions, and academic health centers, promotes the …See details»
Career Opportunities - CeQur Simplicity
CeQur is bringing CeQur Simplicity â„¢ to market, a simple-to-use insulin-delivery patch that makes it easier for people living with diabetes to live life on their own terms. Our simple, 4-day, …See details»
CeQur Receives CE Mark for PaQ® Insulin Delivery Device - PR …
Nov 27, 2012 More information can be found at www.cequrcorp.com. Peyrot M, Rubin RR, Kruger DF, Travis LB. Correlates of insulin injection omission. Diabetes Care 2010;33:240-5.See details»
CeQur - VentureRadar
"CeQur is dedicated to developing and commercializing advanced insulin delivery devices that make it easier for people living with type 2 diabetes to adhere to therapy and stay in control of …See details»
CeQur Raises $115 Million Series C5 Financing to Support ...
Apr 13, 2021 LUCERNE, Switzerland & MARLBOROUGH, Mass.--(BUSINESS WIRE)--CeQur ®, a medical device company committed to simplifying the lives of people with diabetes by …See details»
CeQur raises $115M for wearable insulin delivery device
Apr 13, 2021 CeQur announced today that it closed an oversubscribed equity financing round worth proceeds of $115 million.See details»
Contact Us | CeQur Simplicity Insulin Patch
Our CeQur Caresâ„¢ Team is here to answer questions and get you started with the revolutionary, injection-free CeQur Simplicityâ„¢ wearable insulin patch.See details»
CeQur Raises $115 Million to Support Commercialization & Scale …
CeQur recently announced the close of an oversubscribed $115-million equity financing. The company will use the funds to advance commercial plans for CeQur Simplicity, including …See details»
CeQur is launching a discreet, convenient ‘wearable insulin pen’
Jul 1, 2022 The CeQur Simplicity wearable insulin delivery device. [Image courtesy of CeQur] CeQur designed its Simplicity device to make insulin delivery as seamless as possible for …See details»